Characterization of prescription opioid abuse in the United States: focus on route of administration

PMID: 23675595May 16, 2013Paper

Characterization of prescription opioid abuse in the United States: focus on route of administration

Journal of Pain & Palliative Care Pharmacotherapy

Kenneth L KirshJohn J Coleman

Abstract

Prescription opioids are prescribed increasingly for the management of chronic pain, and this has been accompanied by a dramatic rise in opioid-related abuse, addiction, and overdose deaths. Reports of abuse involving nonoral administration (e.g., snorting, injecting) of prescription opioids are increasing, although the epidemiology of oral versus nonoral abuse is not well understood. Available data indicate that oral abuse is far more common,with 72% to 97% of opioid abusers perferring oral administration. Factors associated with nonoral administration include longer duration of opioid abuse, male gender, and rural setting. Extended-release opioids, because of their relatively high drug load, may be attractive to experienced abusers seeking to manipulate the formulation to facilitate a rapid onset of effect. Putative abuse-deterrent formulations have been developed to decrease the likelihood or consequences of nonoral abuse. In addition, Risk Evaluation and Mitigation Strategies (REMS) are now required for prescribed extended-release/long-acting opioids by the US Food and Drug Administration, although their effectiveness in reducing the risk of abuse, addiction, and overdose has not been evaluated. Physicians should remain vig...Continue Reading

References

Alprazolam absorption kinetics affects abuse liability

Mar 1, 1995·Clinical Pharmacology and Therapeutics·G K MumfordR R Griffiths

Subjective and behavioral effects of diazepam depend on its rate of onset

Jan 1, 1993·Psychopharmacology·H de WitJ Ambre

Prescription opiate abuse in chronic pain patients: clinical criteria, incidence, and predictors

Jun 1, 1997·The Clinical Journal of Pain·C ChabalE Chaney

Oxycodone involvement in drug abuse deaths: a DAWN-based classification scheme applied to an oxycodone postmortem database containing over 1000 cases

Apr 3, 2003·Journal of Analytical Toxicology·Edward J ConeJ David Haddox

Definitions related to the medical use of opioids: evolution towards universal agreement

Jul 10, 2003·Journal of Pain and Symptom Management·Seddon R SavageAaron M Gilson

Behavioral monitoring and urine toxicology testing in patients receiving long-term opioid therapy.

Sep 23, 2003·Anesthesia and Analgesia·Nathaniel P KatzGilbert J Fanciullo

A profile of OxyContin addiction

Sep 2, 2004·Journal of Addictive Diseases·Lon R Hays

Drug crime is a source of abused pain medications in the United States

Nov 1, 2005·Journal of Pain and Symptom Management·David E Joranson, Aaron M Gilson

PET study examining pharmacokinetics, detection and likeability, and dopamine transporter receptor occupancy of short- and long-acting oral methylphenidate.

Mar 4, 2006·The American Journal of Psychiatry·Thomas J SpencerAlan J Fischman

Abuse of prescription drugs and the risk of addiction

Mar 28, 2006·Drug and Alcohol Dependence·Wilson M Compton, Nora D Volkow

Motives, diversion and routes of administration associated with nonmedical use of prescription opioids

Jul 18, 2006·Addictive Behaviors·Sean Esteban McCabeChristian J Teter

Overview of oral modified-release opioid products for the management of chronic pain

Jul 27, 2006·The Annals of Pharmacotherapy·Celene M Amabile, Bill J Bowman

Comparison of fentanyl extraction from two different transdermal patches

Aug 3, 2006·Journal of Forensic Sciences·Robert P Bianchi

Do formulation differences alter abuse liability of methylphenidate? A placebo-controlled, randomized, double-blind, crossover study in recreational drug users

Sep 18, 2007·Journal of Clinical Psychopharmacology·Dolly A ParasrampuriaEdward M Sellers

Challenges in the development of prescription opioid abuse-deterrent formulations

Sep 22, 2007·The Clinical Journal of Pain·Nathaniel P KatzRoger Weiss

Prescription OxyContin abuse among patients entering addiction treatment.

Nov 3, 2007·The American Journal of Psychiatry·Deni CariseKevin G Lynch

The controversy surrounding OxyContin abuse: issues and solutions.

Mar 25, 2008·Therapeutics and Clinical Risk Management·Sujata S Jayawant, Rajesh Balkrishnan

Abuse-deterrent opioid formulations: are they a pipe dream?

May 7, 2008·Current Rheumatology Reports·Nathaniel Katz

What percentage of chronic nonmalignant pain patients exposed to chronic opioid analgesic therapy develop abuse/addiction and/or aberrant drug-related behaviors? A structured evidence-based review

May 21, 2008·Pain Medicine : the Official Journal of the American Academy of Pain Medicine·David A FishbainR Steele Rosomoff

Internet-based survey of nonmedical prescription opioid use in the United States

Jun 25, 2008·The Clinical Journal of Pain·Nathaniel KatzStephen F Butler

Patterns of abuse among unintentional pharmaceutical overdose fatalities

Dec 11, 2008·JAMA : the Journal of the American Medical Association·Aron J HallLeonard J Paulozzi

Clinical guidelines for the use of chronic opioid therapy in chronic noncancer pain.

Feb 4, 2009·The Journal of Pain : Official Journal of the American Pain Society·Roger ChouUNKNOWN American Pain Society-American Academy of Pain Medicine Opioids Guidelines Panel

Opioid deaths in rural Virginia: a description of the high prevalence of accidental fatalities involving prescribed medications.

Feb 17, 2009·The American Journal on Addictions·Martha J WunschWilliam Massello

Opioid formulations in development designed to curtail abuse: who is the target?

Feb 27, 2009·Expert Opinion on Investigational Drugs·Lynn R WebsterRobert A Medve

Relationship between rate of infusion and reinforcing strength of oxycodone in humans

Sep 10, 2009·Journal of Opioid Management·Sandra D ComerRichard W Foltin

Measuring attractiveness for abuse of prescription opioids

Dec 17, 2009·Pain Medicine : the Official Journal of the American Academy of Pain Medicine·Stephen F ButlerNathaniel Katz

Evaluation of the abuse potential of extended release hydromorphone versus immediate release hydromorphone

Jan 16, 2010·Journal of Clinical Psychopharmacology·Megan J ShramEdward M Sellers

Partnerships and pathways of dissemination: the National Institute on Drug Abuse-Substance Abuse and Mental Health Services Administration Blending Initiative in the Clinical Trials Network.

Mar 24, 2010·Journal of Substance Abuse Treatment·Steve MartinoTimothy P Condon

The Food and Drug Administration risk evaluation and mitigation strategy

May 28, 2010·Journal of Pain & Palliative Care Pharmacotherapy·David S Craig

Abuse-deterrent and tamper-resistant opioid formulations: what is their role in addressing prescription opioid abuse?

Sep 16, 2010·CNS Drugs·Jennifer P SchneiderRobert N Jamison

Characteristics of prescription opioid abusers in treatment: prescription opioid use history, age, use patterns, and functional severity

Sep 25, 2010·Journal of Opioid Management·Stephen F ButlerSimon H Budman

Route of administration for illicit prescription opioids: a comparison of rural and urban drug users

Oct 19, 2010·Harm Reduction Journal·April M YoungCarl G Leukefeld

The abuse potential of Remoxy(®), an extended-release formulation of oxycodone, compared with immediate- and extended-release oxycodone

Apr 6, 2011·Pain Medicine : the Official Journal of the American Academy of Pain Medicine·Beatrice SetnikLynn Webster

Characteristics and correlates of men and women with prescription opioid dependence.

Apr 26, 2011·Addictive Behaviors·Sudie E BackKathleen T Brady

Definitions related to the use of pharmaceutical opioids: extramedical use, diversion, non-adherence and aberrant medication-related behaviours

May 7, 2011·Drug and Alcohol Review·Briony LaranceRichard Mattick

Initiation into prescription opioid misuse amongst young injection drug users.

Jun 22, 2011·The International Journal on Drug Policy·Stephen E LankenauMeghan Treese

Attitudes of Florida pharmacists toward implementing a state prescription drug monitoring program for controlled substances

Jul 27, 2011·Journal of Managed Care Pharmacy : JMCP·Jennifer A Fass, Patrick C Hardigan

Current status and evolving role of abuse-deterrent opioids in managing patients with chronic pain

Aug 10, 2011·Journal of Opioid Management·Lynn WebsterEric Voth

A history of being prescribed controlled substances and risk of drug overdose death

Oct 27, 2011·Pain Medicine : the Official Journal of the American Academy of Pain Medicine·Leonard J PaulozziLarry D Loring

Alternate routes of administration and risk for HIV among prescription opioid abusers.

Oct 27, 2011·Journal of Addictive Diseases·Hilary SurrattTheodore J Cicero

Separate and combined psychopharmacological effects of alprazolam and oxycodone in healthy volunteers.

Mar 1, 2012·Drug and Alcohol Dependence·James P ZacnyDennis W Coalson

Opioid extended-release tablets with improved tamper-resistant properties

Jun 14, 2012·Expert Opinion on Drug Delivery·Johannes H BartholomaeusEric Galia

❮ Previous

Next ❯

Citations

Oxycodone/Naloxone: role in chronic pain management, opioid-induced constipation, and abuse deterrence.

Aug 20, 2014·Pain and Therapy·Anne Z DePriest, Katie Miller

Appropriate experimental approaches for predicting abuse potential and addictive qualities in preclinical drug discovery

Sep 2, 2014·Expert Opinion on Drug Discovery·Andy N Mead

Associations between prescription opioid injection and Hepatitis C virus among young injection drug users

Jan 20, 2015·Drugs : Education, Prevention, and Policy·Stephen E LankenauKarol Silva

Update on extended-release opioids in pain management

Dec 5, 2013·Expert Opinion on Drug Delivery·Paul Sloan

Effectiveness and tolerability of low-dose oral oxycodone/naloxone added to anticonvulsant therapy for noncancer neuropathic pain: an observational analysis

Nov 21, 2013·Current Medical Research and Opinion·M LazzariF Leonardis

Dynamic model of nonmedical opioid use trajectories and potential policy interventions

May 20, 2015·The American Journal of Drug and Alcohol Abuse·Wayne WakelandPeter Geissert

Abuse-related adverse drug reactions and abuse deterrent formulations

Oct 23, 2013·Medicina clínica·Esther PapaseitMagí Farré

Medical Judgments Across the Range of Reported Pain Severity: Clinician and Lay Perspectives

Jan 28, 2016·Pain Medicine : the Official Journal of the American Academy of Pain Medicine·Raymond C TaitJoann Biehl

Routes of abuse of prescription opioid analgesics: a review and assessment of the potential impact of abuse-deterrent formulations

Nov 15, 2015·Postgraduate Medicine·Maciej GasiorRichard Malamut

The role of abuse-deterrent formulations in countering opioid misuse and abuse

Nov 26, 2015·Journal of Clinical Pharmacy and Therapeutics·V NguyenJ V Pergolizzi

Predictors of transition to heroin use among initially non-opioid dependent illicit pharmaceutical opioid users: A natural history study

Jan 21, 2016·Drug and Alcohol Dependence·Robert G CarlsonRaminta Daniulaityte

Abuse-Deterrent Opioid Formulations: Pharmacokinetic and Pharmacodynamic Considerations

Jan 1, 2016·Clinical Pharmacokinetics·Carmen WalterJörn Lötsch

Hair testing in postmortem diagnosis of substance abuse: An unusual case of slow-release oral morphine abuse in an adolescent

Oct 23, 2015·Journal of Forensic and Legal Medicine·Valérie Baillif-CouniouAnne-Laure Pelissier-Alicot

Effect of food on the pharmacokinetics of oxycodone and naltrexone from ALO-02, an extended release formulation of oxycodone with sequestered naltrexone

May 4, 2016·Clinical Pharmacology in Drug Development·Kuan GandelmanBimal Malhotra

Abuse-deterrent formulations of prescription opioid analgesics in the management of chronic noncancer pain

Apr 7, 2016·Pain Management·Martin E HaleRichard Malamut

Prescription Opioids. IV: Disposition of Hydrocodone in Oral Fluid and Blood Following Single-Dose Administration

May 13, 2015·Journal of Analytical Toxicology·Edward J ConeRon Flegel

Drug use, hepatitis C, and service availability: perspectives of incarcerated rural women

May 8, 2015·Social Work in Public Health·Michele Staton-TindallCarl G Leukefeld

Prescription opioids. III. Disposition of oxycodone in oral fluid and blood following controlled single-dose administration

Jan 16, 2015·Journal of Analytical Toxicology·Edward J ConeRon Flegel

Oxycodone physical dependence and its oral self-administration in C57BL/6J mice

Jul 10, 2016·European Journal of Pharmacology·Rachel M EngaPatrick M Beardsley

Trends in Narcotic and Corticosteroid Prescriptions in Patients with Inflammatory Bowel Disease in the United States Ambulatory Care Setting from 2003 to 2011

Apr 4, 2017·Inflammatory Bowel Diseases·Neeraj NarulaJean-Frederic Colombel

What's holding back abuse-deterrent opioid formulations? Considering 12 U.S. stakeholders

May 10, 2018·Expert Opinion on Drug Delivery·Joseph V PergolizziRobert B Raffa

Opioid Knowledge and Prescribing Practices Among Obstetrician-Gynecologists

Dec 8, 2017·Obstetrics and Gynecology·Annetta M MadsenKristen A Matteson

Repeat Infective Endocarditis in Persons Who Inject Drugs: "Take Another Little Piece of my Heart"

Dec 18, 2018·Open Forum Infectious Diseases·Glen HuangJames E Peacock

Changes in Reported Injection Behaviors Following the Public Health Response to an HIV Outbreak Among People Who Inject Drugs: Indiana, 2016

Jul 18, 2019·AIDS and Behavior·Sharoda DasguptaJoan Duwve

Oral prescription opioid-seeking behavior in male and female mice.

Sep 7, 2019·Addiction Biology·Alysabeth G PhillipsDavid H Root

Sex differences in oral oxycodone self-administration and stress-primed reinstatement in rats.

Dec 13, 2019·Addiction Biology·Hannah D FulenwiderJesse R Schank

Variability in prescription opioid intake and reinforcement amongst 129 substrains

May 20, 2017·Genes, Brain, and Behavior·S M JimenezK K Szumlinski

Human Abuse Potential of Oral NKTR-181 in Recreational Opioid Users: A Randomized, Double-Blind, Crossover Study.

Sep 26, 2019·Pain Medicine : the Official Journal of the American Academy of Pain Medicine·Xue GeMichael A Eldon

Finding the Hidden Risk Profiles of the United States Opioid Epidemic: Using a Person-Centered Approach on a National Dataset of Noninstitutionalized Adults Reporting Opioid Misuse

Jun 21, 2020·International Journal of Environmental Research and Public Health·Francisco A Montiel IshinoFaustine Williams

The opioid mortality epidemic in North America: do we understand the supply side dynamics of this unprecedented crisis?

Feb 19, 2020·Substance Abuse Treatment, Prevention, and Policy·Benedikt FischerWayne Jones

Patterns of Routes of Administration and Drug Tampering for Nonmedical Opioid Consumption: Data Mining and Content Analysis of Reddit Discussions.

Jan 5, 2021·Journal of Medical Internet Research·Duilio BalsamoRossano Schifanella

Using contact-based education to destigmatize opioid use disorder among medical students.

Nov 17, 2020·Teaching and Learning in Medicine·Sophia C MortElizabeth A Beverly

Developing an animal model to detect drug-drug interactions impacting drug-induced respiratory depression

Feb 6, 2020·Toxicology Reports·Lin XuRodney Rouse

The effect of quinine in two bottle choice procedures in C57BL6 mice: Opioid preference, somatic withdrawal, and pharmacokinetic outcomes.

Aug 24, 2018·Drug and Alcohol Dependence·Travis W GrimLaura M Bohn

Remote local photoactivation of morphine produces analgesia without opioid-related adverse effects.

Aug 8, 2021·British Journal of Pharmacology·Marc López-CanoFrancisco Ciruela

Abuse deterrent immediate release film technology (ADRIFT): A novel bilayer film technology for limiting intentional drug abuse.

Oct 5, 2020·International Journal of Pharmaceutics·Siddhant PalekarKetan Patel

❮ Previous

Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.